Form 4 for NPCE NeuroPace Inc
Accepted 2022-11-02 00:00:00 ET · period of report 2022-10-31 · accession 0001209191-22-055434 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-02 | 2022-10-31 | NPCE | Kuhn Rebecca | CFO | M - OptEx | $0.03 | +1,428 | 59.2K | +2% | +$42.84 |
| DM | 2022-11-02 | 2022-10-31 | NPCE | Kuhn Rebecca | CFO | M - OptEx | $0.00 | -1,428 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-31 | M | A | 482 | $0.03 | 59,704 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-31 | M | A | 692 | $0.03 | 58,968 | D | — | — | |
| 3 | Common | Common Stock | 2022-10-31 | M | A | 254 | $0.03 | 59,222 | D | — | — | |
| 4 | Derivative | Stock Option (Rt to Buy) | 2022-10-31 | M | D | 482 | $0.00 | 0 | D | $0.03 · — to 2025-02-09 | 482 Common Stock | (F1) The share underlying the option are fully vested. |
| 5 | Derivative | Stock Option (Rt to Buy) | 2022-10-31 | M | D | 254 | $0.00 | 0 | D | $0.03 · — to 2024-02-10 | 254 Common Stock | (F1) The share underlying the option are fully vested. |
| 6 | Derivative | Stock Option (Rt to Buy) | 2022-10-31 | M | D | 692 | $0.00 | 0 | D | $0.03 · — to 2022-11-12 | 692 Common Stock | (F1) The share underlying the option are fully vested. |